News | September 02, 2025
Zydus launches VaxiFlu vaccine for flu protection
First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO)
First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO)
The sudden subsequent decision to suspend IXCHIQ is based on updated VAERS data
Accro will retain global rights to develop, manufacture, and commercialize AC-201 (excluding Chinese Mainland, Hong Kong SAR, and Macau SAR)
The updated formula for Spikevax is now approved for individuals 6 months through 64 years of age
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
Attorney General Ken Paxton sued pharmaceutical giant Eli Lilly for bribing and illegally inducing medical providers to prescribe its most profitable drugs
Pfizer's vaccine helps protect against clinically relevant 20 serotypes responsible for a majority of invasive and non-invasive pneumococcal disease
The system, called GeneAgent, cross-checks its own initial predictions for accuracy against information from established, expert-curated databases
Moderna's updated COVID-19 mRNA vaccine will be available for the 2025-2026 vaccination season, pending a European Commission authorization decision
Milestone also announced the extension of its $75 million Royalty Purchase Agreement with RTW Investments
Subscribe To Our Newsletter & Stay Updated
